Evidence map›Paper›PMID 41367990›Full record

ArticleJAACAP open2025

Cannabis Use is Related to Anhedonia in Adolescents With Diverse Mood and Anxiety Symptoms.

Tram N B Nguyen, Benjamin A Ely, Aria Vitale, Chloe Roske, Jasmin T Richard, Russell H Tobe, Vilma Gabbay

Abstract read
In one paragraph

Article in JAACAP open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Altered reward-related resting-state network properties in adolescent cannabis use and depression.Progress in neuro-psychopharmacology & biological psychiatry · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tram N B NguyenAlbert Einstein College of Medicine, Bronx, New York.
Benjamin A ElyUniversity of Miami Leonard M. Miller School of Medicine, Miami, Florida.
Aria VitaleMedStar Georgetown University Hospital, Washington, District of Columbia.
Chloe RoskeHarvard University, Cambridge, Massachusetts.
Jasmin T RichardIcahn School of Medicine at Mount Sinai, New York, New York.
Russell H TobeNathan S. Kline Institute for Psychiatric Research, Orangeburg, New York.
Vilma GabbayNathan S. Kline Institute for Psychiatric Research, Orangeburg, New York.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Youth with depression use cannabis at high rates, and exposure to cannabinoids in adolescence has been shown to deleteriously alter the reward system. However, there has been sparse research on the link between adolescent cannabis use and anhedonia, a core symptom of depression and clinical manifestation of reward dysfunction. Here, in a sample of adolescents presenting predominantly with mood and anxiety symptoms, we investigated the relationships between cannabis use and anticipatory and consummatory aspects of anhedonia. Method: Adolescents underwent psychiatric diagnostic interviews and completed dimensional symptom measures. Cannabis use was quantified using information from clinician interviews, self-reports, and urine toxicology screenings. Bivariate associations between cannabis use and anhedonia subconstructs were determined. To further assess associations adjusting for age and sex, linear regression models were performed. We additionally explored how cannabis use was related to other mood and anxiety symptoms, as well as age and sex effects. Results: Among 153 participants (age: 15.9 ± 2.2 years, 64.1% biologically female), we identified 49 who used cannabis. Primary analyses showed that relative to those who never used or had only tried cannabis once, adolescents who used cannabis endorsed worse anticipatory anhedonia. More frequent cannabis use also correlated with greater anticipatory anhedonia. Exploratory analyses revealed that adolescents diagnosed with cannabis use disorder reported greater depression and anxiety than those with non-disordered cannabis use, and female and male youth differed in their experiences of mood and anxiety symptoms related to cannabis use. Conclusion: Our findings have important public health implications as policies on cannabis evolve. We advocate for the detection and interventions specific to anhedonia for the management of cannabis use in youth with internalizing conditions. Diversity & Inclusion Statement: We worked to ensure sex and gender balance in the recruitment of human participants. We worked to ensure race, ethnic, and/or other types of diversity in the recruitment of human participants. One or more of the authors of this paper self-identifies as a member of one or more historically underrepresented racial and/or ethnic groups in science. One or more of the authors of this paper self-identifies as a member of one or more historically underrepresented sexual and/or gender groups in science. We actively worked to promote sex and gender balance in our author group. We actively worked to promote inclusion of historically underrepresented racial and/or ethnic groups in science in our author group. While citing references scientifically relevant for this work, we also actively worked to promote sex and gender balance in our reference list. While citing references scientifically relevant for this work, we also actively worked to promote inclusion of historically underrepresented racial and/or ethnic groups in science in our reference list. The author list of this paper includes contributors from the location and/or community where the research was conducted who participated in the data collection, design, analysis, and/or interpretation of the work.We worked to ensure that the study questionnaires were prepared in an inclusive way.

Indexed as

anhedoniaanxietycannabisdepressionsuicidality

Identifiers

PMID41367990
PMCPMC12684445

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.